Skip to main content
ABCL
NASDAQ Life Sciences

AbCellera to Release Phase 2 Menopause Drug Data Monday; Shares Jump 8%

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$7.49
Mkt Cap
$2.125B
52W Low
$2.745
52W High
$8.44
52W Position info
173% above low
Off High info
11% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

ABCL has more than doubled off its 52-week low of $2.745.

Summary

AbCellera will release top-line Phase 2 data for ABCL635, its non-hormonal menopause symptom drug, before market open Monday. The stock surged 8% in after-hours trading to $7.48, reflecting anticipation of a potential catalyst. This follows a series of positive developments, including major collaborations with Jazz and Vertex and a strengthened cash position. The data readout could validate the company's internal pipeline and drive further upside if results are strong.

At the time of this announcement, ABCL was trading at $7.49 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.1B. The 52-week trading range was $2.75 to $8.44. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

ABCL - Latest Insights

ABCL
Nov 09, 2026, 4:22 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $12.54
Real-time Price: $9.78 info
Change: -$2.76 (-22%) info
Market Cap: $3.165B info
ABCL
Nov 09, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $12.90
Real-time Price: $9.78 info
Change: -$3.12 (-24%) info
Market Cap: $3.165B info
ABCL
Aug 13, 2026, 4:33 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $10.97
Real-time Price: $9.78 info
Change: -$1.19 (-11%) info
Market Cap: $3.165B info
ABCL
Aug 13, 2026, 12:05 AM EDT
Source: BusinessWire
Importance Score:
9
Price at Filing: $10.32
Real-time Price: $9.78 info
Change: -$0.540 (-5%) info
Market Cap: $3.165B info
ABCL
Aug 11, 2026, 4:59 PM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $9.32
Real-time Price: $9.78 info
Change: +$0.460 (+5%) info
Market Cap: $3.165B info